Navigation Links
Insight for Hot Flashes In Postmenopausal Women

Researchers in the latest issue of Harvard Women’s Health Watch had explored the physiology// of hot flashes experienced by some women in their menopausal or postmenopausal age.

Hot flashes are well known to most menopausal women—and to many who are in peri-menopause, the transition to menopause. Hot flashes tend to come on suddenly and last from one to five minutes; they can range in severity from fleeting warmth to a feeling of being on fire.

Although the physiology of hot flashes has been studied for more than 30 years, no one is completely sure why or how they occur. One possible explanation has to do with an individual’s tolerance for temperature changes. One line of research shows that women who have hot flashes have a lower tolerance for changes in the body’s core (innermost) temperature than women who don’t have hot flashes.

Normally, the body tries to maintain its core temperature within a comfortable “thermoneutral zone.” When core body temperature crosses the upper threshold of this zone, sweating occurs; when it drops below the lower threshold, shivering results.

Women who have hot flashes have a thermoneutral zone that’s so narrow, even the tiniest changes in core body temperature can trigger sweating (or chills). These symptoms are generally absent in women with a wider thermoneutral zone, explains the Harvard Women’s Health Watch.

The authors also discussed why the thermoneutral zone is narrower in women with hot flashes and strategies for managing symptoms, including hormone therapy, medications that affect brain chemicals, and a method of breathing called paced respiration.

Source: Newswise

Medindia on Menopause: further information

Menopause: This is the condition of reproductive ageing for women. It begins at around the age of 40 years when the menstrual periods become irregular. Hormones levels of estrogen and progeste rone declines and this may cause a variety of health problems like hot flashes, vaginal dryness, and end of having menstruation periods. /font>
'"/>




Related medicine news :


1. fMRI Offers Insight Into An Infants Brain
2. New Insight To The Role Of Peptide Signals
3. New Insight Gained For Allergic Reactions
4. New Insight In Periodontal Disease In Postmenopausal Women
5. Researchers Bring New Insight To Asthma And SABA Fills
6. Study Unveils New Insight To The Madness Of King George III
7. Study Offers Insights Into Treatment Of Rheumatoid Arthritis
8. Reindeer Provide Valuable Insights Into Sleep Disorders
9. Insight Into The Risky Health Decisions On Bird Flu
10. Cure Insight for DMD
11. Insights Into Lead Pollution
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... CT (PRWEB) , ... March 28, 2017 , ... ... devices, announces today that the University of Pittsburgh Medical Center (UPMC) will acquire ... and Western Pennsylvania. , The program, developed in association with efforts by the ...
(Date:3/28/2017)... ... March 28, 2017 , ... Calibration, qualification, and the ... results and maintaining GMP and USP compliance. In a new webinar from METTLER ... requirements " these requirements are explained. The challenge is to determine how ...
(Date:3/28/2017)... ... March 28, 2017 , ... With less than 10,000 dermatologists in the ... care can be limited while the desire to conquer breakouts and eliminate skincare stress ... for every customer online, today released its inaugural survey on the State of Acne ...
(Date:3/28/2017)... ... March 28, 2017 , ... Columbus OH. Dr. Justin Harper, Founder of Juvly ... professionals in the country to sit on the 2017 National Advisory Board for Allergan’s ... years Dr. Harper helped propel the clinic from a small start-up to number 78 ...
(Date:3/28/2017)... PA (PRWEB) , ... March 28, 2017 , ... Public ... and across a variety of business channels. , While many results are clear, ... any public relations program. , When it comes to measurement, firms should always ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... 2017  AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a ... commercialization of innovative therapies for the treatment of ... Agency (EMA) has notified the company that the ... Application (MAA) has passed validation, and that the ... MAA for ARX-04 (known as DSUVIA™ in the ...
(Date:3/28/2017)... MARLBOROUGH, Mass. , March 28, 2017 /PRNewswire/ ... RNAi company developing innovative therapeutics that address significant ... granted a patent from the Japan Patent Office ... targeting connective tissue growth factor (CTGF) for the ... not limited to skin fibrosis and proliferative retinopathy ...
(Date:3/28/2017)... 28, 2017 The global ... 8.0 billion by 2025, according to a new study ... infectious diseases and cancer is expected to upsurge the ... over the coming years. In addition, higher number of ... allogenic stem cell therapy, due to adverse effects caused ...
Breaking Medicine Technology: